Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-06-01
|
Series: | Acta Neuropathologica Communications |
Online Access: | https://doi.org/10.1186/s40478-024-01818-8 |